Ara 290 and Sermorelin Interaction: Synergistic | Peptide Database

Join others researching Thymulin — share findings, ask questions, and learn from real experiences Thymulin is a nonapeptide hormone exclusively secreted by thymic epithelial cells, discovered by Jean-François Bach in the 1970s. Unlike thymalin (a peptide extract mixture), thymulin is a single, defined 9-amino-acid peptide that requires zinc binding for biological activity. It plays a crucial role in T-cell differentiation and maturation within the thymus. Serum thymulin levels decline significantly with age and zinc deficiency, contributing to age-related immune decline (immunosenescence). Research has explored thymulin's potential in restoring immune function, managing autoimmune conditions, and as an anti-inflammatory agent. Thymulin exerts its effects through binding to high-affinity receptors on T-lymphocytes and other immune cells. The zinc-thymulin complex is the biologically active form - without zinc, the peptide has no immunological activity. Thymulin promotes: (1) differentiation of immature T-cells into mature T-cell subsets, (2) modulation of cytokine release including IL-2 and interferon-gamma, (3) regulation of T-helper and T-suppressor cell balance, (4) enhancement of NK cell activity, and (5) anti-inflammatory effects through suppression of pro-inflammatory mediators. It also has neuroendocrine effects, influencing the hypothalamic-pituitary-adrenal axis.

Join others researching Erythropoietin (EPO) — share findings, ask questions, and learn from real experiences Erythropoietin (EPO) is an essential glycoprotein hormone that stimulates red blood cell production. Naturally produced by the kidneys in response to low oxygen levels, recombinant human EPO is FDA-approved for treating anemia in chronic kidney disease and chemotherapy patients. EPO binding to receptors on bone marrow cells promotes survival and maturation of red blood cell precursors, increasing oxygen-carrying capacity. Due to performance-enhancing effects, it is banned in competitive sports. EPO binds to erythropoietin receptors (EPOR) on erythroid progenitor cells in bone marrow, activating three interconnected signaling pathways: JAK2/STAT5, PI3K/AKT, and RAS/MAPK. This promotes survival of red blood cell precursors by protecting them from apoptosis, accelerates proliferation and differentiation of erythroid cells, and increases hemoglobin production. Under hypoxic stress, endogenous EPO production can increase up to 1000-fold, demonstrating the body's powerful oxygen-sensing regulatory system.